Mary Ann Gray
Director · 1 filing · Latest: Jun 3, 2026
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KROS | Mary Ann Gray | Director | Jun 3, 2026 | Grant/Award | $0.00 | 7,142 | — | 12,392 |
Director · 1 filing · Latest: Jun 3, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KROS | Mary Ann Gray | Director | Jun 3, 2026 | Grant/Award | $0.00 | 7,142 | — | 12,392 |